Allbright v. Teva Pharmaceuticals USA, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Allbright v. Teva Pharmaceuticals USA, Inc.

Sort by

Viewing results 1‒5 of 5

Pharmaceuticals sector
Mylan drops as AGs look to expand generic drug-pricing lawsuit
...The companies now under investigation are: Heritage Pharmaceuticals, Inc.; Aurobindo Pharma USA, Inc.; Citron Pharma, LLC; Mayne Pharma (USA), Inc.; Mylan Pharmaceuticals, Inc.; Teva Pharmaceuticals USA;...
October 31, 2017
World
EU steps up drug groups’ probe
...Europe’s competition watchdog has stepped up its probe into whether pharmaceutical companies are paying rivals to delay the introduction of generic competition for their medicines....
January 12, 2010
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
World
Probe on generic drugs is stepped up by EU
...Last July, the Commission began studying deals between Servier of France and the generic companies Krka, Lupin, Matrix and Teva over the blood pressure medicine perindopril....
January 20, 2010
Work & Careers
The big defence challenge
...A US court of appeal ruled in favour of a patent challenge by Teva Pharmaceutical, an Israeli generic drugmaker, overturning a lower court ruling that upheld Merck’ s patent for the once-weekly dose of Fosamax...
April 20, 2005
Asia-Pacific equities
Aventis sparks patent battle with Teva
...s Teva Pharmaceutical Industries. Aventis said the move was a response to Teva Pharmaceuticals USA?s recent application to market its generic version of Actonel, an osteoporosis treatment, in the US....
August 17, 2004

Previous pagePage 1 of 1Next page